Markel Group’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-33,000
Closed -$5.4M 142
2017
Q4
$5.4M Hold
33,000
0.1% 98
2017
Q3
$6.76M Hold
33,000
0.13% 95
2017
Q2
$8.02M Buy
33,000
+6,000
+22% +$1.41M 0.17% 90
2017
Q1
$6.45M Buy
27,000
+13,000
+93% +$3.03M 0.15% 93
2016
Q4
$2.94M Buy
14,000
+12,000
+600% +$2.49M 0.07% 107
2016
Q3
$461K Buy
+2,000
New +$489K 0.01% 123

Other funds holding AGN

Markel Group's AGN Position: Q1 2018 in Review

Markel Group sold out of Allergan plc (AGN) in Q1 2018, closing a stake of 33,000 shares — an estimated $5.4M sold.

Markel Group first reported a position in AGN in Q3 2016 and held it in 6 quarters. The position peaked at $8.02M in Q2 2017. 1,022 funds tracked by Wall St. Rank hold AGN as of Q1 2018.

  • Markel Group reported no remaining Allergan plc position as of Q1 2018 after selling out during the quarter.
  • Markel Group sold 33,000 Allergan plc shares in Q1 2018, an estimated $5.4M.
  • Markel Group first reported a position in Allergan plc in Q3 2016 and held it in 6 quarters.
  • Markel Group's Allergan plc position peaked at $8.02M in Q2 2017.
  • 1,022 funds tracked by Wall St. Rank held Allergan plc as of Q1 2018.

Based on Markel Group's 13F filing for Q1 2018, filed 27 Apr 2018.